Mutation Detection Kits In Genome Editing Market Outlook 2026–2030: Growth Trends, Market Dynamics And Emerging Opportunities
Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Mutation Detection Kits In Genome Editing Market Size Forecast: How Big Could The Market Get By 2030?
The market for mutation detection kits in genome editing has experienced significant expansion recently. Its size is expected to climb from $1.14 billion in 2025 to $1.29 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.2%. In the past, this growth was influenced by the limited availability of mutation detection kits, a dependence on manual and traditional detection techniques, the growth in genome editing research, an increasing need for precise validation tools, and the adoption of basic nucleic acid reagents.
The mutation detection kits in genome editing market size is projected to experience swift expansion over the coming years. This market is set to reach a value of $2.1 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 13.0%. This anticipated growth during the forecast period is driven by factors such as the creation of sophisticated CRISPR-based mutation validation kits, increased spending on next-generation sequencing technologies, the proliferation of cloud-based bioinformatics solutions, a growing number of applications in clinical diagnostics and personalized medicine, and the incorporation of AI-powered data interpretation tools. Key trends anticipated during this period encompass the growing acceptance of PCR-based and next-generation sequencing mutation detection kits, wider utilization of CRISPR mutation validation instruments in genome editing research, the advancement of software tools for genomic data analysis and visualization, broader implementation of mutation detection in drug development and clinical diagnostics, and the integration of cloud-based bioinformatics platforms for immediate data interpretation.
Get A Free Sample Report With In-Depth Market Insights:
Mutation Detection Kits In Genome Editing Market Opportunity Drivers: What’s Unlocking New Revenue Potential?
An anticipated increase in the occurrence of genetic disorders is set to drive the expansion of mutation detection kits within the genome editing market. These disorders are defined as illnesses or conditions stemming from irregularities in a person’s DNA, potentially inherited from parents or arising from novel genetic mutations. Increased public understanding and sophisticated diagnostic tools contribute to this surge, facilitating prompt and precise identification of such conditions, which in turn leads to elevated reported incidence rates. Crucially, genome editing mutation detection kits play a vital role in tackling genetic disorders by precisely pinpointing disease-causing gene mutations, thereby facilitating focused research and the creation of accurate treatment approaches. An illustrative example comes from May 2024, where the National Health Service, a UK government body, reported that about 17,000 individuals in England are affected by sickle cell disease, an inherited blood disorder, with around 250 new diagnoses occurring annually. Consequently, the growing frequency of genetic disorders is indeed a key factor fueling the demand for mutation detection kits in the genome editing market.
Mutation Detection Kits In Genome Editing Market Segment Breakdown: Which Categories Lead On Revenue?
The mutation detection kits in genome editing market covered in this report is segmented –
1) By Product Type: Reagents, Kits, Software Solutions
2) By Technology: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Transcription Activator-Like Effector Nucleases Or Meganuclease-TAL Effector Nucleases (TALENs/MegaTALs), Zinc Finger Nucleases (ZFN), Other Technologies
3) By Application: Research, Clinical Diagnostics, Drug Development, Other Applications
4) By End Use: Academic Institutions, Hospitals And Diagnostic Centers, Biotechnology Companies
Subsegments:
1) By Reagents: Deoxyribonucleic Acid Polymerases (DNA) Polymerases, Nucleases, Buffers And Enzymes, Fluorescent Dyes And Probes, Primers And Oligonucleotides
2) By Kits: Polymerase Chain Reaction (PCR)-Based Mutation Detection Kits, Next-Generation Sequencing-Based Mutation Analysis Kits, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Mutation Validation Kits, Gel Electrophoresis-Based Detection Kits
3) By Software Solutions: Mutation Analysis And Visualization Tools, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Off-Target Prediction Software, Genomic Alignment and Annotation Software, Data Interpretation Platforms For Next-Generation Sequencing, Cloud-Based Bioinformatics Platforms
Mutation Detection Kits In Genome Editing Market Innovation Trends Shaping Future Development
Leading companies in the mutation detection kits segment of the genome editing market are concentrating on developing advanced products, such as ultrasensitive multiplexed assays, to enhance the accuracy, speed, and sensitivity in identifying genetic mutations. These ultrasensitive multiplexed assays are sophisticated diagnostic tests capable of concurrently detecting and quantifying multiple genetic mutations even at very low levels, which aids researchers and clinicians in achieving faster, more accurate, and comprehensive mutation analysis for improved disease diagnosis and treatment monitoring. For example, in April 2024, Bio-Rad Laboratories Inc., a US-based research company, introduced the ddPLEX ESR1 Mutation Detection Kit, an ultrasensitive multiplexed digital PCR assay specifically designed for breast cancer mutation detection. This kit allows for the simultaneous identification and precise quantification of seven ESR1 mutations with an analytical sensitivity reaching 0.01% variant allele fraction, supporting both plasma and tissue sample analysis. Such innovations underscore the industry’s commitment to enhancing diagnostic accuracy and enabling more effective disease monitoring and personalized treatment strategies.
Mutation Detection Kits In Genome Editing Market Leading Players And Competitive Positioning
Major companies operating in the mutation detection kits in genome editing market are F. Hoffmann-La Roche Ltd, Merck KGaA, Thermo Fisher Scientific Inc., QIAGEN N.V., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Integrated DNA Technologies Inc., GenScript Biotech Corporation, Takara Bio Inc., Promega Corporation, Analytik Jena AG, Twist Bioscience Corporation, New England Biolabs Inc., Applied Biological Materials Inc., Synthego Corporation, BioVision Inc., Creative Biogene Corporation
View The Full Mutation Detection Kits In Genome Editing Market Report:
Mutation Detection Kits In Genome Editing Market Largest Region By Revenue And Market Share
North America was the largest region in the mutation detection kits in genome editing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mutation detection kits in genome editing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
